Invention Grant
- Patent Title: Benzimidazole derivatives as raf kinase inhibitors
- Patent Title (中): 苯并咪唑衍生物作为raf激酶抑制剂
-
Application No.: US10564185Application Date: 2004-06-15
-
Publication No.: US07691886B2Publication Date: 2010-04-06
- Inventor: Hans-Peter Buchstaller , Dirk Finsinger , Matthias Wiesner , Lars Thore Burgdorf , Christiane Amendt , Matthias Grell , Christian Sirrenberg , Frank Zenke
- Applicant: Hans-Peter Buchstaller , Dirk Finsinger , Matthias Wiesner , Lars Thore Burgdorf , Christiane Amendt , Matthias Grell , Christian Sirrenberg , Frank Zenke
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Arent Fox LLP
- Priority: EP03015582 20030711
- International Application: PCT/EP2004/006419 WO 20040615
- International Announcement: WO2005/004864 WO 20050120
- Main IPC: C07D401/00
- IPC: C07D401/00 ; A01N43/64
Abstract:
The present invention relates to benzimidazole derivatives of formula I, the use of the compounds of formula I as inhibitors of one or more kinases, the use of the compounds of formula I for the manufacture of a pharmaceutical compositions and methods of treatment, comprising administering said pharmaceutical compositions to patients.
Public/Granted literature
- US20070010560A1 Benzimidazole derivatives as raf kinase inhibitors Public/Granted day:2007-01-11
Information query
